FI940192A0 - 2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina - Google Patents

2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina

Info

Publication number
FI940192A0
FI940192A0 FI940192A FI940192A FI940192A0 FI 940192 A0 FI940192 A0 FI 940192A0 FI 940192 A FI940192 A FI 940192A FI 940192 A FI940192 A FI 940192A FI 940192 A0 FI940192 A0 FI 940192A0
Authority
FI
Finland
Prior art keywords
alkonol
hydroxypiperidino
anesthetics
derivatives
alkonol derivatives
Prior art date
Application number
FI940192A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI940192L (fi
FI940192A7 (fi
Inventor
Jr Willard Mckowan Welch
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI940192L publication Critical patent/FI940192L/fi
Publication of FI940192A7 publication Critical patent/FI940192A7/fi
Publication of FI940192A0 publication Critical patent/FI940192A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI940192A 1991-07-17 1992-06-19 2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina FI940192A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73157791A 1991-07-17 1991-07-17
PCT/US1992/004973 WO1993002052A1 (en) 1991-07-17 1992-06-19 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents

Publications (3)

Publication Number Publication Date
FI940192L FI940192L (fi) 1994-01-14
FI940192A7 FI940192A7 (fi) 1994-01-14
FI940192A0 true FI940192A0 (fi) 1994-01-14

Family

ID=24940103

Family Applications (2)

Application Number Title Priority Date Filing Date
FI940192A FI940192A0 (fi) 1991-07-17 1992-06-19 2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina
FI981956A FI981956A7 (fi) 1991-07-17 1992-06-19 2-(4-hydroksipiperidino)-1-alkanolijohdannaisia verettömyyden vastaisi a aineina

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI981956A FI981956A7 (fi) 1991-07-17 1992-06-19 2-(4-hydroksipiperidino)-1-alkanolijohdannaisia verettömyyden vastaisi a aineina

Country Status (22)

Country Link
EP (1) EP0594729A1 (enrdf_load_stackoverflow)
JP (1) JP2571904B2 (enrdf_load_stackoverflow)
KR (1) KR0165003B1 (enrdf_load_stackoverflow)
CN (1) CN1043759C (enrdf_load_stackoverflow)
AU (1) AU655840B2 (enrdf_load_stackoverflow)
BR (1) BR9206272A (enrdf_load_stackoverflow)
CA (1) CA2113568A1 (enrdf_load_stackoverflow)
CZ (1) CZ284133B6 (enrdf_load_stackoverflow)
EG (1) EG20048A (enrdf_load_stackoverflow)
FI (2) FI940192A0 (enrdf_load_stackoverflow)
HU (1) HUT70528A (enrdf_load_stackoverflow)
IE (1) IE922311A1 (enrdf_load_stackoverflow)
IL (1) IL102473A (enrdf_load_stackoverflow)
MX (1) MX9204190A (enrdf_load_stackoverflow)
NO (1) NO180445C (enrdf_load_stackoverflow)
NZ (1) NZ243580A (enrdf_load_stackoverflow)
PL (1) PL169884B1 (enrdf_load_stackoverflow)
PT (1) PT100689B (enrdf_load_stackoverflow)
RU (1) RU2065859C1 (enrdf_load_stackoverflow)
TW (1) TW201732B (enrdf_load_stackoverflow)
WO (1) WO1993002052A1 (enrdf_load_stackoverflow)
ZA (1) ZA925306B (enrdf_load_stackoverflow)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
JP2695292B2 (ja) * 1992-10-30 1997-12-24 フアイザー・インコーポレイテツド 神経保護性３，４−ジヒドロ−（１ｈ）−キノロン化合物
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
US6978166B2 (en) 1994-10-07 2005-12-20 Saint Louis University System for use in displaying images of a body part
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
CA2220649C (en) * 1996-12-03 2007-02-13 F. Hoffmann-La Roche Ag 4-hydroxy-piperidine derivatives
CA2369695A1 (en) * 1999-04-09 2000-10-19 Manabu Itoh Agent for treating neuropathic pain
TWI254043B (en) * 1999-06-08 2006-05-01 Hoffmann La Roche Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor
AU1153601A (en) 1999-10-29 2001-05-08 Merck Sharp & Dohme Limited Method to treat pain utilizing benzimidazole NMDA NR2B antagonists
US6495561B2 (en) 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
US6489477B1 (en) 1999-10-29 2002-12-03 Merck & Co., Inc. 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
US6291499B1 (en) 1999-10-29 2001-09-18 Merck & Co., Inc. 2-cyclohexyl benzimidazole NMDA/NR2B antagonists
US6316474B1 (en) 1999-10-29 2001-11-13 Merck & Co., Inc. 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
US6432976B1 (en) 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6476041B1 (en) 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
US6369076B1 (en) 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
US6380205B1 (en) 1999-10-29 2002-04-30 Merck & Co., Inc. 2-cyclohexyl quinazoline NMDA/NR2B antagonists
YU64303A (sh) 2001-02-23 2006-05-25 Merck & Co.Inc. N-supstituisani nearil-heterociklični antagonisti nmda/nr2b
AU2002338334B8 (en) 2001-04-03 2008-09-18 Merck & Co., Inc. N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B antagonists
WO2004048326A1 (ja) 2002-11-25 2004-06-10 Mochida Pharmaceutical Co., Ltd. ４−ヒドロキシピペリジン誘導体を有効成分とする呼吸器疾患治療剤
BRPI0415113A (pt) * 2003-10-08 2006-11-28 Pfizer compostos de lactama condensados
TWI409289B (zh) 2010-09-02 2013-09-21 Taiwan Union Technology Corp 由氮氧雜環化合物所製得之聚合物之穩態溶液及其製法與用途
EP4168116A4 (en) * 2020-06-23 2024-07-10 Biohaven Therapeutics Ltd. Topical formulations of (1s)-1-phenyl-2-pyridin-2-ylethanamine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2546166B1 (fr) * 1983-05-19 1985-10-25 Synthelabo Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
EP0398578B1 (en) * 1989-05-17 1997-03-12 Pfizer Inc. 2-piperidino-1-alkanol derivatives as antiischemic agents
JPH0699423B2 (ja) * 1990-05-10 1994-12-07 フアイザー・インコーポレイテツド 神経保護性インドロン及び関連誘導体

Also Published As

Publication number Publication date
ZA925306B (en) 1994-01-17
CZ400892A3 (en) 1994-03-16
IL102473A0 (en) 1993-01-14
NO180445C (no) 1997-04-23
EG20048A (en) 1997-03-27
JP2571904B2 (ja) 1997-01-16
FI981956A0 (fi) 1998-09-11
FI940192L (fi) 1994-01-14
NO940144D0 (no) 1994-01-14
IE922311A1 (en) 1993-01-27
KR0165003B1 (en) 1999-01-15
EP0594729A1 (en) 1994-05-04
PL169884B1 (pl) 1996-09-30
CZ284133B6 (cs) 1998-08-12
CN1043759C (zh) 1999-06-23
WO1993002052A1 (en) 1993-02-04
BR9206272A (pt) 1995-04-11
RU2065859C1 (ru) 1996-08-27
AU2322592A (en) 1993-02-23
NO180445B (no) 1997-01-13
FI981956L (fi) 1998-09-11
NO940144L (no) 1994-01-14
HU9400136D0 (en) 1994-05-30
PT100689A (pt) 1993-10-29
FI940192A7 (fi) 1994-01-14
AU655840B2 (en) 1995-01-12
CA2113568A1 (en) 1993-02-04
FI981956A7 (fi) 1998-09-11
MX9204190A (es) 1993-01-01
IL102473A (en) 1997-07-13
JPH06504293A (ja) 1994-05-19
CN1068566A (zh) 1993-02-03
NZ243580A (en) 1994-10-26
HUT70528A (en) 1995-10-30
PT100689B (pt) 1999-06-30
TW201732B (enrdf_load_stackoverflow) 1993-03-11

Similar Documents

Publication Publication Date Title
FI940192A0 (fi) 2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina
FI924069L (fi) Terapeutiskt anvaendbara peptider och peptidfragment
FI921640L (fi) Superabsorberande polymer med foerbaettrade absorptionsegenskaper
FI930737A7 (fi) Asialoglykoproteiiniin sidottu lääkeaine
FI923379L (fi) Terapeutiska amider
DE69222622D1 (de) Spritze
FI923581A7 (fi) Farmaseuttinen yhdistelmämuodostelu
NO923859D0 (no) Medikament
FI925849A7 (fi) Tiazolidinfoereningar, deras framstaellning och terapeutiska anvaendningar
FI924744L (fi) Terapeutiska aemnen
NO940210D0 (no) Lukke for medikamentbroenn
FI943581A0 (fi) Ruisku
FI923759L (fi) Terapeutiska bensazapinfoereningar
DE69229852D1 (de) Vernetzbare Polymerzusammensetzung
FI925827A7 (fi) Silloitettavissa oleva polymeerikoostumus
FI921786A7 (fi) Farmaceutisk foerening
FI921785A7 (fi) Farmaceutisk foerening
DK56591D0 (da) Toerringsfremgangsmaade
FI924614A7 (fi) Vaermevaexlare med hoeg effekt och hygien
FI931015A0 (fi) 2-(2-substituerade pyrrolidinyltio)karbapenemderivat
FI920701L (fi) Anordning foer terapeutisk tryckbehandling
KR920021041U (ko) 세척기
NO942783D0 (no) Spröyte
NO924553D0 (no) Avstembar mikroboelgeoscillator
NO941294L (no) Tioformamid-derivat